SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 3rd, 2019 • CorMedix Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of December 31, 2018, is by and among CorMedix Inc., a Delaware corporation with offices located at 400 Connell Drive, 5th Floor, Berkeley Heights, NJ 07922 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
CORMEDIX INC. SECOND Amended and Restated Warrant To Purchase Common StockSecurities Purchase Agreement • January 3rd, 2019 • CorMedix Inc. • Pharmaceutical preparations • New York
This Second Amended and Restated Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”) of CorMedix Inc. (the “Company”) is issued this 31st day of December, 2018, and amends and restates the Warrant to Purchase Common Stock issued by the Company on October 22, 2013 (the “Issuance Date”) _________________ (the “Holder”) pursuant to that certain Securities Purchase Agreement dated October 17, 2013 (the “Securities Purchase Agreement”), which Warrant to Purchase Common Stock was subsequently amended and restated on September 15, 2014. The Company hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Holder or its permitted assigns is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant, at any time or times on or a
CORMEDIX INC. THIRD AMENDED AND RESTATED WARRANT TO PURCHASE COMMON STOCKCorMedix Inc. • January 3rd, 2019 • Pharmaceutical preparations • New York
This Third Amended and Restated Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”) of CorMedix Inc. (the “Company”) is issued this 31st day of December 2018, and amends and restates the Warrant to Purchase Common Stock issued by the Company on May 30, 2013 (the “Issuance Date”) to Manchester Securities Corp. (the “Holder”), pursuant to that certain Securities Purchase Agreement dated May 23, 2013 (the “Securities Purchase Agreement”), which Warrant to Purchase Common Stock was subsequently amended and restated on September 15, 2014 and March 3, 2015. The Company hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Holder or its permitted assigns is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant, at any
CORMEDIX INC. Warrant To Purchase Common StockCorMedix Inc. • January 3rd, 2019 • Pharmaceutical preparations • New York
This Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”) of CorMedix Inc. (the “Company”) is issued this 31st day of December, 2018 (the “Issuance Date”) to Manchester Securities Corp. (the “Holder”) pursuant to that certain Securities Purchase Agreement, dated the Issuance Date (the “Purchase Agreement”). The Company hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Holder or its permitted assigns is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant, at any time or times on or after the Issue Date (the “Initial Exercisability Date”), but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), four hundred fifty thousand (450,000) shares of Common Stock (subject to adjustment as
